Ogushi, K.; Yokobori, T.; Nobusawa, S.; Shirakura, T.; Hirato, J.; Erkhem-Ochir, B.; Okami, H.; Dorjkhorloo, G.; Nishi, A.; Suzuki, M.;
et al. High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma. Cancers 2023, 15, 4482.
https://doi.org/10.3390/cancers15184482
AMA Style
Ogushi K, Yokobori T, Nobusawa S, Shirakura T, Hirato J, Erkhem-Ochir B, Okami H, Dorjkhorloo G, Nishi A, Suzuki M,
et al. High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma. Cancers. 2023; 15(18):4482.
https://doi.org/10.3390/cancers15184482
Chicago/Turabian Style
Ogushi, Kenjiro, Takehiko Yokobori, Sumihito Nobusawa, Takahiro Shirakura, Junko Hirato, Bilguun Erkhem-Ochir, Haruka Okami, Gendensuren Dorjkhorloo, Akira Nishi, Makoto Suzuki,
and et al. 2023. "High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma" Cancers 15, no. 18: 4482.
https://doi.org/10.3390/cancers15184482
APA Style
Ogushi, K., Yokobori, T., Nobusawa, S., Shirakura, T., Hirato, J., Erkhem-Ochir, B., Okami, H., Dorjkhorloo, G., Nishi, A., Suzuki, M., Otake, S., Saeki, H., & Shirabe, K.
(2023). High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma. Cancers, 15(18), 4482.
https://doi.org/10.3390/cancers15184482